Concepedia

Daniel Tobias Michaeli

DT

21

Publications

570

Citations

16

H-Index

1969

Active since

Affiliations

Heidelberg University(Current)

University Medical Centre Mannheim

University Hospital Heidelberg

German Cancer Research Center

University of Wuppertal

Daniel Tobias Michaeli is an author at Heidelberg University specializing in health economics, public health, and health policy.

Top concepts

Public HealthHealth EconomicsMedicineHealth PolicyHealth Services ResearchHealthNursingOncologyEducationEmployment

Publications per year

1969–2024

21

Publications

21

Overall Survival, Progression-Free Survival, and Tumor Response Benefit Supporting Initial US Food and Drug Administration Approval and Indication Extension of New Cancer Drugs, 2003-2021

Daniel Tobias Michaeli, Thomas Michaeli · Journal of Clinical Oncology · 2022 · 97 citations

FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications: cross sectional analysis

Thomas Michaeli, Hendrik Jürges, Daniel Tobias Michaeli · BMJ · 2023 · 44 citations · Full text

Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland

Daniel Tobias Michaeli, Mackenzie Mills, Panos Kanavos · Applied Health Economics and Health Policy · 2022 · 42 citations · Full text

The Healthcare Workforce Shortage of Nurses and Physicians: Practice, Theory, Evidence, and Ways Forward

Daniel Tobias Michaeli, Julia Caroline Michaeli, Sebastian Albers et al. · Policy Politics & Nursing Practice · 2024 · 41 citations

Healthcare Provision, Education, Health Care Management +20

Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA

Daniel Tobias Michaeli, Mackenzie Mills, Thomas Michaeli et al. · Investigational New Drugs · 2022 · 37 citations · Full text

Rows per page

1–5 of 21